换一批Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
第一作者：
Miguel,de la Hoya
第一单位：
Molecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Hospital Clinico San Carlos, Madrid, Spain amanda.spurdle@qimr.edu.au mhoya@hotmail.com.
作者：
Miguel,de la Hoya [1]
;
Omar,Soukarieh [2]
;
Irene,López-Perolio [3]
;
Ana,Vega [4]
;
Logan C,Walker [5]
;
Yvette,van Ierland [6]
;
Diana,Baralle [7]
;
Marta,Santamariña [8]
;
Vanessa,Lattimore [5]
;
Juul,Wijnen [9]
;
Philip,Whiley [10]
;
Ana,Blanco [4]
;
Michela,Raponi [7]
;
Jan,Hauke [11]
;
Barbara,Wappenschmidt [11]
;
Alexandra,Becker [11]
;
Thomas V O,Hansen [12]
;
Raquel,Behar [3]
;
KConFaB,Investigators [13]
;
Diether,Niederacher [14]
;
Norbert,Arnold [15]
;
Bernd,Dworniczak [16]
;
Doris,Steinemann [17]
;
Ulrike,Faust [18]
;
Wendy,Rubinstein [19]
;
Peter J,Hulick [20]
;
Claude,Houdayer [21]
;
Sandrine M,Caputo [22]
;
Laurent,Castera [23]
;
Tina,Pesaran [24]
;
Elizabeth,Chao [24]
;
Carole,Brewer [25]
;
Melissa C,Southey [26]
;
Christi J,van Asperen [6]
;
Christian F,Singer [27]
;
Jan,Sullivan [28]
;
Nicola,Poplawski [29]
;
Phuong,Mai [30]
;
Julian,Peto [31]
;
Nichola,Johnson [32]
;
Barbara,Burwinkel [33]
;
Harald,Surowy [33]
;
Stig E,Bojesen [34]
;
Henrik,Flyger [35]
;
Annika,Lindblom [36]
;
Sara,Margolin [37]
;
Jenny,Chang-Claude [38]
;
Anja,Rudolph [39]
;
Paolo,Radice [40]
;
Laura,Galastri [41]
;
Janet E,Olson [42]
;
Emily,Hallberg [42]
;
Graham G,Giles [43]
;
Roger L,Milne [43]
;
Irene L,Andrulis [44]
;
Gord,Glendon [45]
;
Per,Hall [46]
;
Kamila,Czene [46]
;
Fiona,Blows [47]
;
Mitul,Shah [47]
;
Qin,Wang [48]
;
Joe,Dennis [48]
;
Kyriaki,Michailidou [49]
;
Lesley,McGuffog [48]
;
Manjeet K,Bolla [48]
;
Antonis C,Antoniou [48]
;
Douglas F,Easton [48]
;
Fergus J,Couch [50]
;
Sean,Tavtigian [51]
;
Maaike P,Vreeswijk [6]
;
Michael,Parsons [10]
;
Huong D,Meeks [51]
;
Alexandra,Martins [2]
;
David E,Goldgar [52]
;
Amanda B,Spurdle [53]
作者单位：
Molecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Hospital Clinico San Carlos, Madrid, Spain amanda.spurdle@qimr.edu.au mhoya@hotmail.com.
[1]
Inserm U1079-IRIB, University of Rouen, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
[2]
Molecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Hospital Clinico San Carlos, Madrid, Spain.
[3]
Fundacion Publica Galega de Medicina Xenómica-SERGAS Grupo de Medicina Xenómica-USC, IDIS, CIBERER, Santiago de Compostela 15706, Spain.
[4]
Department of Pathology, University of Otago, Christchurch 8140, New Zealand.
[5]
Department of Clinical Genetics, Leiden University Medical Centre, Leiden 2300, The Netherlands.
[6]
Human Development and Health, Faculty of Medicine, University of Southampton, Southampton S016 5YA, UK.
[7]
CIBERER, Grupo de Medicina Xenómica-USC, Universidade de Santiago de Compostela, Fundacion Galega de Medicina Xenómica (SERGAS), Santiago de Compostela 15706, Spain.
[8]
Department of Clinical Genetics, Leiden University Medical Centre, Leiden 2300, The Netherlands Department of Clinical Genetics, Leiden University Medical Centre, Leiden 2300, The Netherlands.
[9]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
[10]
Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hosptial Cologne, Cologne 50931, Germany.
[11]
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen DK-2100, Denmark.
[12]
Peter MacCallum Cancer Center, University of Melbourne, Melbourne, VIC 3002, Australia.
[13]
Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf 40225, Germany.
[14]
Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel 24105, Germany.
[15]
Institute of Human Genetics, University of Münster, Münster 48149, Germany.
[16]
Institute of Human Genetics, Hannover Medical School, Hannover 30625, Germany.
[17]
Institute of Medical Genetics and Applied Genomics, University Hospital Tuebingen, Tuebingen 72076, Germany.
[18]
National Institutes of Health, Bethesda, MD 20892-2152, USA.
[19]
Center for Medical Genetics, NorthShore University Health System, University of Chicago Pritzker School of Medicine, Evanston, IL 60201, USA.
[20]
Service de Génétique, Department de Biologie des Tumeurs, Institut Curie and INSERM U830, Centre de Recherche de l'Institut Curie, Paris, and Universite Paris Descartes, Sorbonne Paris Cite, Paris 75248, France.
[21]
Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris 75248, France.
[22]
Centre Francois Baclesse, Laboratoire de Biologie et de Genetique du Cancer, 14076 Caen, Paris 75248, France.
[23]
Ambry Genetics, Aliso Viejo, CA 92656, USA.
[24]
Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK.
[25]
Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.
[26]
Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria, Waehringer Guertel 18-20, A 1090 Vienna, Austria.
[27]
Genetic Health Service NZ, South Island Hub, Christchurch Hospital, Christchurch 8140, New Zealand.
[28]
Adult Genetics Unit, South Australian Clinical Genetics Service, SA Pathology at the Women's and Children's Hospital, North Adelaide, SA 5067, Australia University Department of Paediatrics, University of Adelaide, North Terrace, Adelaide, SA 5000, Australia.
[29]
Clinical Genetics Branch, DCEG, NCI, NIH, Bethesda, MD, USA.
[30]
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
[31]
Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK Division of Breast Cancer Research, Institute of Cancer Research, London SW3 6JB, UK.
[32]
Molecular Biology of Breast Cancer, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg 69120, Germany Molecular Epidemiology Group, German Cancer Research Center, DKFZ, Heidelberg 69120, Germany.
[33]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen 2730, Denmark Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev 2730, Denmark Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 1165, Denmark.
[34]
Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Denmark.
[35]
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-171 77, Sweden.
[36]
Department of Oncology Pathology, Karolinska Institutet, Stockholm SE-171 77, Sweden.
[37]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
[38]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
[39]
Unit of "Molecular bases of genetic risk and genetic testing", Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20139, Italy.
[40]
Associazione Volontari Italiani Sangue (AVIS) comunale di Milano, Milano 20139, Italy.
[41]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
[42]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, VIC 3010, Australia Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
[43]
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada Department of Molecular Genetics, University of Toronto, M5B 1W8, Canada.
[44]
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
[45]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-171 77, Sweden.
[46]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
[47]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
[48]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 1683, Nicosia, Cyprus.
[49]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
[50]
Department of Oncological Sciences.
[51]
Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
[52]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia amanda.spurdle@qimr.edu.au mhoya@hotmail.com.
[53]
医学主题词
成年人(Adult);老年人(Aged);选择性剪接(Alternative Splicing);BRCA1蛋白质(BRCA1 Protein);乳腺肿瘤(Breast Neoplasms);DNA突变分析(DNA Mutational Analysis);外显子(Exons);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);中年人(Middle Aged);突变(Mutation);卵巢肿瘤(Ovarian Neoplasms);RNA剪接位点(RNA Splice Sites);RNA剪接(RNA Splicing);肿瘤抑制蛋白质类(Tumor Suppressor Proteins)
DOI
10.1093/hmg/ddw094
PMID
27008870
发布时间
2025-06-23
- 浏览66
Human molecular genetics
Human molecular genetics
2256-2268页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
